Last10K.com

Affimed N.V. (AFMD) SEC Filing 20-F Annual report for the fiscal year ending Sunday, December 31, 2017

Affimed N.V.

HISTORY TOOLS
CIK: 1608390 Ticker: AFMD

View differences made from one year to another to evaluate Affimed N.V.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Affimed N.V..

Continue

Assess how Affimed N.V.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Affimed N.V.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Statement Of Cash Flows
Consolidated Statement Of Changes In Equity
Consolidated Statement Of Comprehensive Loss
Consolidated Statement Of Financial Position
1. Reporting Entity
10. Finance Income And Finance Costs
10. Finance Income And Finance Costs (details)
10. Finance Income And Finance Costs (tables)
11. Income Taxes
11. Income Taxes (details Narrative)
11. Income Taxes (details)
11. Income Taxes (tables)
12. Trade And Other Receivables
12. Trade And Other Receivables (details Narrative)
13. Other Assets
14. Financial Assets
15. Equity
15. Equity (details)
16. Share Based Payments
16. Share Based Payments (details Narrative)
16. Share Based Payments (details)
16. Share Based Payments (tables)
17. Borrowings
17. Borrowings (details Narrative)
17. Borrowings (details)
17. Borrowings (tables)
18. Trade And Other Payables
18. Trade And Other Payables (details Narrative)
19. Loss Per Share
19. Loss Per Share (details)
19. Loss Per Share (tables)
2. Basis Of Preparation ??? Consolidated Financial Statements
20. Operating Leases And Other Commitments And Contingencies
20. Operating Leases And Other Commitments And Contingencies (details Narrative)
20. Operating Leases And Other Commitments And Contingencies (details)
20. Operating Leases And Other Commitments And Contingencies (tables)
21. Related Parties
21. Related Parties (details 1)
21. Related Parties (details Narrative)
21. Related Parties (details)
21. Related Parties (tables)
22. Financial Risk Management
22. Financial Risk Management (details Narrative)
22. Financial Risk Management (details)
22. Financial Risk Management (tables)
23. Subsequent Events
3. Significant Accounting Policies
3. Significant Accounting Policies (details)
3. Significant Accounting Policies (policies)
3. Significant Accounting Policies (tables)
4. Segment Reporting
4. Segment Reporting (details)
4. Segment Reporting (tables)
5. Revenue
5. Revenue (details Narrative)
6. Other Income And Expenses ??? Net
6. Other Income And Expenses ??? Net (details Narrative)
7. Research And Development Expenses
7. Research And Development Expenses (details)
7. Research And Development Expenses (tables)
8. General And Administrative Expenses
8. General And Administrative Expenses (details)
8. General And Administrative Expenses (tables)
9. Employee Benefits
9. Employee Benefits (details Narrative)
9. Employee Benefits (details)
9. Employee Benefits (tables)
Ticker: AFMD
CIK: 1608390
Form Type: 20-F Annual Report
Accession Number: 0000950103-18-003510
Submitted to the SEC: Tue Mar 20 2018 7:31:31 AM EST
Accepted by the SEC: Tue Mar 20 2018
Period: Sunday, December 31, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/afmd/0000950103-18-003510.htm